Other
Immunization
0
Pipeline Programs↗
4
Active Trials↗
7
Companies Involved↗
Immunization is an early-stage landscape with 0 programs across 7 companies. The most active players are GSK, Livzon Pharmaceutical Group Inc., Sanofi.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
60
clinical trials
Completed47 · 78%
Unknown status6 · 10%
Active, not recruiting3 · 5%
Suspended1 · 2%
Terminated1 · 2%
Not yet recruiting1 · 2%
Other1 · 2%
Clinical Trials
Trial Activity
60 trials
The Study of Immunization in People Living With HIV Undergoing an ATI for Elicitation of VRC01-lineage Antibodies
Active, not recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT06006546·35 enrolled
The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products
Active, not recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 4·NCT06551506·181 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)